Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 3.550
0.00 (0.00%)
Oct 10, 2025, 4:05 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 24.75 million as of October 10, 2025. Its market cap has decreased by -48.17% in one year.
Market Cap
24.75M
Enterprise Value
14.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.55
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 24.75M, a decrease of -53.95%. That is a compound annual growth rate of -16.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 24.75M | -30.28% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.29B |
| Smith & Nephew | 11.51B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.10B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.75B |